Device Trial Radar · NCT07279220
Safety and Effectiveness of the Vascular Closure Device for Femoral Artery Hemostasis in Patients of Femoral Artery Puncture
Last checked: Nov 20, 2026Latest source record: Dec 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
238
Planned (sponsor's estimate)
Start
Dec 29, 2025
Primary completion
Mar 2, 2026
Study completion May 15, 2026
Sponsor
- Lead sponsor
- Shanghai Bomaian Medical Technology Co., LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 12, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to verify the safety and effectiveness of the Vascular Closure Device manufactured by Shanghai Bomaian Medical Technology Co., Ltd. for femoral artery hemostasis in patients of femoral artery puncture.
Conditions
- Femoral Artery Puncture
- Vascular Closure Device
- Hemostasis
Interventions
Vascular Closure Device Manufactured by Shanghai Bomaian Medical Technology Co., Ltd.Device
The test group will use the Vascular Closure Device manufactured by Shanghai Bomaian Medical Technology Co., Ltd. for femoral artery hemostasis in patients of femoral artery puncture
MynxGrip Vascular Closure Device Manufactured by Cordis US CorpDevice
The control group will use MynxGrip Vascular Closure Device Manufactured by Cordis US Corp for femoral artery hemostasis in patients of femoral artery puncture
Primary outcomes
What the sponsor says the trial is designed to measure.
- Device Success RateTime frame: Intra-procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Second Affiliated Hospital of Army Medical University (PLA)
Chongqing, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.